SOUTH SAN FRANCISCO, Calif., May 26, 2023 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on May 25, 2023, the Compensation Committee of IDEAYA’s Board of Directors granted non-qualified stock options to purchase an aggregate of 17,800 shares of … Read more
HELSINKI et ZURICH, 26 mai 2023 /PRNewswire/ — Ductor, une société de biotechnologie circulaire de premier plan dans le domaine du biogaz et des engrais organiques, et TotalEnergies, l’entreprise mondiale multiénergie, annoncent aujourd’hui un nouveau partenariat commercial et financier avec le développement conjoint de sites de production et la prise de participation de TotalEnergies dans … Read more
PUNE, India, May 26, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Idiopathic Gastroparesis Drugs Market by Drug (Antiemetic Drugs, Prokinetic Drugs, and Others), Route of Administration (Oral, Intravenous, Nasal, and Transdermal), Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies), and Region: Size, Share, Trends and Opportunity Analysis, … Read more
NEW YORK, May 26, 2023 /PRNewswire/ — To encourage everyone to take small steps for sun safety, American Skin Association (ASA) announced that it has partnered with the National Council on Skin Cancer Prevention and its broad coalition of member organizations to designate the Friday before Memorial Day as “Don’t Fry Day”. This announcement comes … Read more
STOCKHOLM, May 26, 2023 /PRNewswire/ — GomSpace releases its Q1 2023, and the CEO outlines plans for bringing the company to profitability FIRST QUARTER OF 2023 Order intake was T.SEK 33,454 (41,497) Net revenues of T.SEK 78,150 are in line with Q1 2022 (78,365) Gross margin this quarter is positive 12%, compared to negative 26% for … Read more
OSLO, Norway, May 26, 2023 /PRNewswire/ — Following the closing of the acceptance period in the previously announced public offer, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, will become the owner of 96.33 per cent of the share capital and votes and 93.16 per cent … Read more
Supporting FivepHusion’s Global Development and Commercialization Strategy SYDNEY, May 26, 2023 /PRNewswire/ — FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, and Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, to develop and bring … Read more
HSINCHU, 26 mai 2023 /PRNewswire/ — La fabrication intelligente et le contrôle rigoureux des processus améliorent la qualité du TPU. ICP DAS – BMP (Polymères biomédicaux), un fournisseur de TPU (polyuréthane thermoplastique) de qualité médicale basé à Taïwan, agit comme un précurseur qui déploie des systèmes IIoT dans une usine intelligente pour maintenir la cohérence entre les lots dans … Read more
SHANGHAI, 26 mai 2023 /PRNewswire/ — BioRay Pharmaceutical Co. (ci-après dénommée BioRay) a annoncé que la demande de nouveau médicament de recherche (IND) pour l’essai clinique de son produit exclusif BRY812, un nouveau conjugué anticorps-médicament (ADC) ciblant la LIV-1 humaine pour le traitement des tumeurs malignes avancées, a été acceptée par l’Administration nationale chinoise des produits médicaux (NMPA) … Read more
SHANGHAI, 26. Mai 2023 /PRNewswire/ –BioRay Pharmaceutical Co Ltd. (im Folgenden als BioRay bezeichnet) (BioRay) gab bekannt, dass der IND-Antrag (Investigational New Drug) für die klinische Erprobung des firmeneigenen BRY812, eines neuartigen Antikörper-Wirkstoff-Konjugats (ADC), das auf menschliches LIV-1 zur Behandlung fortgeschrittener bösartiger Tumore abzielt, von der China National Medical Products Administration (NMPA) angenommen wurde (Zulassungsnummer … Read more